IBM's Watson Gains Commercial Acceptance in US
Double blinded validation study to assess performance of IBM artificial intelligence platform Watson for oncology in comparison with Manipal multidisciplinary tumor board--first study of 638 breast cancer cases.
Feb-15-2017, 06:06:36 GMT
- Country:
- North America > United States
- Texas > Bexar County > San Antonio (0.06)
- Asia
- North America > United States
- Genre:
- Research Report > Experimental Study (0.54)
- Industry:
- Health & Medicine > Therapeutic Area > Oncology (1.00)
- Technology: